Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intraventricular rt-PA plus low-frequency rotational therapy after severe aneurysmal subarachnoid hemorrhage
ISRCTN13230264Phase 2Completed
- Sponsor
- Heinrich Heine University Düsseldorf
- Start
- Dec 2008
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, open-label trial of tissue-plasminogen activator in subarachnoid hemorrhage (SAH) (2 arms), sponsored by Heinrich Heine University Düsseldorf. Primary endpoint: Glasgow outcome score at discharge and after 6 weeks. Started Dec 2008; status: completed.
02
Drugs
tissue-plasminogen activator
03
Conditions
subarachnoid hemorrhage (SAH)
Beyond the preview
Go deeper on ISRCTN13230264.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN13230264.